Project: Sugar-modified Vaccine Epitopes; Exploration and Translation
| Acronym | SVEET (Reference Number: 114695) |
| Duration | 01/04/2021 - 01/04/2024 |
| Project Topic | SVEET will develop •A vaccine protecting against urinary tract infection; infections that can be lethal for hospitalized patients. The vaccine will be at the pre-clinical Proof of Concept stage (PoC) at TRL4, ready for licensing/partnering (GlyProVac) •PoC for both the proprietary technology BEMAP and the importance of O-linked protein glycosylation in subunit vaccines (GlyProVac) •A new rapid service for the identification and application of peptide mimotopes of unknown structures (Epitopic) |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 14 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Fraunhofer Gesellschaft | Partner | Germany |
| 2 | epitopic GmbH | Partner | Germany |
| 3 | GlyProVac ApS | Coordinator | Denmark |
| 4 | Odense University Hospital CM | Partner | Denmark |